{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:02:22Z","timestamp":1787061742218,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-11120-y","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:05:35Z","timestamp":1760360735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Emerging roles of Midnolin in Cancer, Parkinson\u2019s Disease, and Metabolic dysfunction"],"prefix":"10.1007","volume":"52","author":[{"given":"Madhur","family":"Kalyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpana","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"issue":"1\u2013","key":"11120_CR1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0378-1119(00)00259-6","volume":"254","author":"M Tsukahara","year":"2000","unstructured":"Tsukahara M, Suemori H, Noguchi S, Ji ZS, Tsunoo H (2000) Novel nucleolar protein, midnolin, is expressed in the mesencephalon during mouse development. Gene 254(1\u2013):45\u201355","journal-title":"Gene"},{"issue":"6660","key":"11120_CR2","volume":"381","author":"X Gu","year":"2023","unstructured":"Gu X, Nardone C, Kamitaki N, Mao A, Elledge SJ, Greenberg ME (2023) The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. Science 381(6660):eadh5021","journal-title":"Science"},{"key":"11120_CR3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.devcel.2016.05.013","volume":"376","author":"J Du","year":"2016","unstructured":"Du J, Zhang J, He T, Li Y, Su Y, Tie F et al (2016) Stuxnet facilitates the degradation of polycomb protein during development. Dev Cell 376:507\u2013519","journal-title":"Dev Cell"},{"key":"11120_CR4","doi-asserted-by":"crossref","unstructured":"Zhao Z, Zhao X, He T, Wu X, Lv P, Zhu AJ et al (2021) Epigenetic regulator Stuxnet modulates octopamine effect on sleep through a Stuxnet-Polycomb-Oct\u03b22R cascade. EMBO Rep. ;22[2]:e47910.","DOI":"10.15252\/embr.201947910"},{"key":"11120_CR5","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.molcel.2025.05.030","volume":"8513","author":"C Nardone","year":"2025","unstructured":"Nardone C, Gao J, Seo HS, Mintseris J, Ort L, Yip MCJ et al (2025) Structural basis for the midnolin-proteasome pathway and its role in suppressing myeloma. Mol Cell 8513:2597\u20132609e11","journal-title":"Mol Cell"},{"issue":"19","key":"11120_CR6","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2505345122","volume":"122","author":"N Peddada","year":"2025","unstructured":"Peddada N, Zhong X, Yin Y, Lazaro DR, Wang J, Lyon S et al (2025) Structural insights into the ubiquitin-independent midnolin-proteasome pathway. Proc Natl Acad Sci U S A 122(19):e2505345122","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11120_CR7","doi-asserted-by":"crossref","first-page":"35824","DOI":"10.1074\/jbc.M113.526632","volume":"28850","author":"A Hofmeister-Brix","year":"2013","unstructured":"Hofmeister-Brix A, Kollmann K, Langer S, Schultz J, Lenzen S, Baltrusch S (2013) Identification of the ubiquitin-like domain of Midnolin as a new glucokinase interaction partner. J Biol Chem 28850:35824\u201335839","journal-title":"J Biol Chem"},{"key":"11120_CR8","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/acn3.50914","volume":"611","author":"Y Obara","year":"2019","unstructured":"Obara Y, Sato H, Nakayama T, Kato T, Ishii K (2019) Midnolin is a confirmed genetic risk factor for parkinson\u2019s disease. Ann Clin Transl Neurol 611:2205\u20132211","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"11120_CR9","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20232132","volume":"221","author":"X Zhong","year":"2024","unstructured":"Zhong X, Peddada N, Moresco JJ, Wang J, Jiang Y, Rios JJ et al (2024) Viable mutations of mouse Midnolin suppress B cell malignancies. J Exp Med 221(6):e20232132","journal-title":"J Exp Med"},{"key":"11120_CR10","doi-asserted-by":"crossref","first-page":"G147","DOI":"10.1152\/ajpgi.00011.2023","volume":"3252","author":"SM Kweon","year":"2023","unstructured":"Kweon SM, Irimia-Dominguez J, Kim G, Fueger PT, Asahina K, Lai KK et al (2023) Heterozygous Midnolin knockout attenuates severity of nonalcoholic fatty liver disease in mice fed a Western-style diet high in fat, cholesterol, and Fructose. Am J Physiol Gastrointest Liver Physiol 3252:G147\u2013G157","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"11120_CR11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jbior.2016.05.001","volume":"62","author":"S Bahrami","year":"2016","unstructured":"Bahrami S, Drabl\u00f8s F (2016) Gene regulation in the immediate-early response process. Adv Biol Regul 62:37\u201349","journal-title":"Adv Biol Regul"},{"key":"11120_CR12","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2018.00079","volume":"12","author":"FT Gallo","year":"2018","unstructured":"Gallo FT, Katche C, Morici JF, Medina JH, Weisstaub NV (2018) Immediate early genes, memory and psychiatric disorders: focus on c-Fos, Egr1 and Arc. Front Behav Neurosci 12:79","journal-title":"Front Behav Neurosci"},{"key":"11120_CR13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pharmthera.2012.09.001","volume":"1371","author":"S Healy","year":"2013","unstructured":"Healy S, Khan P, Davie JR (2013) Immediate early response genes and cell transformation. Pharmacol Ther 1371:64\u201377","journal-title":"Pharmacol Ther"},{"issue":"1","key":"11120_CR14","doi-asserted-by":"crossref","DOI":"10.3390\/v12010110","volume":"12","author":"CS Adamson","year":"2020","unstructured":"Adamson CS, Nevels MM (2020) Bright and early: inhibiting human cytomegalovirus by targeting major immediate-early gene expression or protein function. Viruses 12(1):110","journal-title":"Viruses"},{"key":"11120_CR15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.leukres.2018.07.025","volume":"72","author":"A Agnarelli","year":"2018","unstructured":"Agnarelli A, Chevassut T, Mancini EJ (2018) IRF4 in multiple myeloma\u2014biology, disease and therapeutic target. Leuk Res 72:52\u201358","journal-title":"Leuk Res"},{"key":"11120_CR16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fnmol.2015.00078","volume":"8","author":"K Minatohara","year":"2016","unstructured":"Minatohara K, Akiyoshi M, Okuno H (2016) Role of immediate-early genes in synaptic plasticity and neuronal ensembles underlying the memory trace. Front Mol Neurosci 8:78","journal-title":"Front Mol Neurosci"},{"key":"11120_CR17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.abb.2019.01.011","volume":"663","author":"SM Sternisha","year":"2019","unstructured":"Sternisha SM, Miller BG (2019) Molecular and cellular regulation of human glucokinase. Arch Biochem Biophys 663:199\u2013213","journal-title":"Arch Biochem Biophys"},{"key":"11120_CR18","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.bbamcr.2014.02.006","volume":"18436","author":"KS Cullen","year":"2014","unstructured":"Cullen KS, Al-Oanzi ZH, O\u2019Harte FPM, Agius L, Arden C (2014) Glucagon induces translocation of glucokinase from the cytoplasm to the nucleus of hepatocytes by transfer between 6-phosphofructo 2-kinase\/fructose 2,6-bisphosphatase-2 and the glucokinase regulatory protein. Biochim Biophys Acta 18436:1123\u20131134","journal-title":"Biochim Biophys Acta"},{"key":"11120_CR19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.semcdb.2020.04.011","volume":"108","author":"F Seebacher","year":"2020","unstructured":"Seebacher F, Zeigerer A, Kory N, Krahmer N (2020) Hepatic lipid droplet homeostasis and fatty liver disease. Semin Cell Dev Biol 108:72\u201381","journal-title":"Semin Cell Dev Biol"},{"key":"11120_CR20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1248\/bpb.b17-00663","volume":"411","author":"Y Obara","year":"2018","unstructured":"Obara Y, Ishii K (2018) Transcriptome analysis reveals that Midnolin regulates mrna expression levels of multiple parkinson\u2019s disease causative genes. Biol Pharm Bull 411:20\u201323","journal-title":"Biol Pharm Bull"},{"key":"11120_CR21","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/acn3.51012","volume":"74","author":"KJ Billingsley","year":"2020","unstructured":"Billingsley KJ, Bandres-Ciga S, Ding J, Hernandez D, Gibbs JR, Blauwendraat C et al (2020) MIDN locus structural variants and parkinson\u2019s disease risk. Ann Clin Transl Neurol 74:602\u2013603","journal-title":"Ann Clin Transl Neurol"},{"key":"11120_CR22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jns.2017.08.3251","volume":"381","author":"K Kaur","year":"2017","unstructured":"Kaur K, Gill JS, Bansal PK, Deshmukh R (2017) Neuroinflammation - a major cause for striatal dopaminergic degeneration in parkinson\u2019s disease. J Neurol Sci 381:308\u2013314","journal-title":"J Neurol Sci"},{"issue":"2","key":"11120_CR23","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L (2012) \u0391-synuclein in parkinson\u2019s disease. Cold Spring Harb Perspect Med 2(2):a009399","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"11120_CR24","volume":"15","author":"P Ge","year":"2020","unstructured":"Ge P, Dawson VL, Dawson TM (2020) PINK1 and parkin mitochondrial quality control: a source of regional vulnerability in Parkinson\u2019s disease. Mol Neurodegener 15(1):20","journal-title":"Mol Neurodegener"},{"key":"11120_CR25","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1016\/j.febslet.2015.10.021","volume":"589","author":"D Haddad","year":"2015","unstructured":"Haddad D, Nakamura K (2015) Understanding the susceptibility of dopamine neurons to mitochondrial stressors in parkinson\u2019s disease. FEBS Lett 589:3702\u20133713 [24 0 0]","journal-title":"FEBS Lett"},{"issue":"1","key":"11120_CR26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-05456-0","volume":"7","author":"Y Obara","year":"2017","unstructured":"Obara Y, Imai T, Sato H, Takeda Y, Kato T, Ishii K (2017) Midnolin is a novel regulator of parkin expression and is associated with parkinson\u2019s disease. Sci Rep 7(1):5885","journal-title":"Sci Rep"},{"issue":"2","key":"11120_CR27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/biomedicines13020276","volume":"13","author":"XG Zhang","year":"2025","unstructured":"Zhang XG, Li WT, Jin X, Fu C, Jiang W, Bai J et al (2025) Comprehensive analysis reveals Midnolin as a potential prognostic, therapeutic, and immunological cancer biomarker. Biomedicines 13(2):276","journal-title":"Biomedicines"},{"issue":"6","key":"11120_CR28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061421","volume":"14","author":"SM Kweon","year":"2022","unstructured":"Kweon SM, Kim G, Jeong Y, Huang W, Lee JS, Lai KKY (2022) Midnolin regulates liver cancer cell growth in vitro and in vivo. Cancers (Basel) 14(6):1421","journal-title":"Cancers (Basel)"},{"key":"11120_CR29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2147\/JHC.S450423","volume":"11","author":"K Wu","year":"2024","unstructured":"Wu K, Lin F (2024) Lipid metabolism as a potential target of liver cancer. J Hepatocell Carcinoma 11:327\u2013346","journal-title":"J Hepatocell Carcinoma"},{"issue":"6","key":"11120_CR30","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70472","volume":"29","author":"S Huang","year":"2025","unstructured":"Huang S, Zhang J, He T, Zhou J, Liu Z (2025) Midnolin correlates with anti-tumour immunity and promotes liver cancer progression through \u03b2-catenin. J Cell Mol Med 29(6):e70472","journal-title":"J Cell Mol Med"},{"key":"11120_CR31","doi-asserted-by":"crossref","unstructured":"Xu C, Xu Z, Zhang Y, Evert M, Calvisi DF, Chen X (2022) \u03b2-Catenin signaling in hepatocellular carcinoma. J Clin Invest [Internet]. Feb 15 [cited 2025 Apr 11];132[4]. Available from: https:\/\/www.jci.org\/articles\/view\/154515","DOI":"10.1172\/JCI154515"},{"issue":"5","key":"11120_CR32","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1182\/blood-2011-11-394346","volume":"120","author":"CL Kriss","year":"2012","unstructured":"Kriss CL, Pinilla-Ibarz JA, Mailloux AW, Powers JJ, Tang CHA, Kang CW et al (2012) Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice. Blood 120(5):1027\u20131038","journal-title":"Blood"},{"issue":"1","key":"11120_CR33","volume":"18","author":"Y Niu","year":"2019","unstructured":"Niu Y, Lin Z, Wan A, Chen H, Liang H, Sun L et al (2019) RNA n6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer 18(1):46","journal-title":"Mol Cancer"},{"key":"11120_CR34","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/cac2.12075","volume":"4010","author":"Y Xu","year":"2020","unstructured":"Xu Y, Ye S, Zhang N, Zheng S, Liu H, Zhou K et al (2020) The FTO\/miR-181b-3p\/ARL5B signaling pathway regulates cell migration and invasion in breast cancer. Cancer Commun [Lond] 4010:484\u2013500","journal-title":"Cancer Commun [Lond]"},{"issue":"1","key":"11120_CR35","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3724\/abbs.2023267","volume":"56","author":"J Ni","year":"2024","unstructured":"Ni J, Lu X, Gao X, Jin C, Mao J (2024) Demethylase FTO inhibits the occurrence and development of triple-negative breast cancer by blocking m 6A-dependent miR-17-5p maturation-induced ZBTB4 depletion. Acta Biochim Biophys Sin [Shanghai] 56(1):114\u2013128","journal-title":"Acta Biochim Biophys Sin [Shanghai]"},{"issue":"1","key":"11120_CR36","volume":"13","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Wang Q, Deng H, Xu B, Zhou Y, Liu J et al (2022) N6-methyladenosine demethylase FTO promotes growth and metastasis of gastric cancer via m6A modification of caveolin-1 and metabolic regulation of mitochondrial dynamics. Cell Death Dis 13(1):72","journal-title":"Cell Death Dis"},{"issue":"12","key":"11120_CR37","volume":"13","author":"YY Xu","year":"2023","unstructured":"Xu YY, Li T, Shen A, Bao XQ, Lin JF, Guo LZ (2023) FTO up-regulation induced by MYC suppresses tumour progression in Epstein-Barr virus-associated gastric cancer. Clin Transl Med 13(12):e1505","journal-title":"Clin Transl Med"},{"key":"11120_CR38","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.2147\/JIR.S503326","volume":"18","author":"X Guan","year":"2025","unstructured":"Guan X, Xu L, Liu J, Fei H, Wang C (2025) Single-cell sequencing and transcriptome analysis explored changes in Midnolin-Related immune microenvironment and constructed combined prognostic model for pancreatic cancer. J Inflamm Res 18:2975\u20132990","journal-title":"J Inflamm Res"},{"key":"11120_CR39","volume":"11","author":"B Wang","year":"2021","unstructured":"Wang B, Guo H, Yu H, Chen Y, Xu H, Zhao G (2021) The role of the transcription factor EGR1 in cancer. Front Oncol 11:642547","journal-title":"Front Oncol"},{"key":"11120_CR40","volume":"14","author":"D Song","year":"2023","unstructured":"Song D, Lian Y, Zhang L (2023) The potential of activator protein 1 [AP-1] in cancer targeted therapy. Front Immunol 14:1224892","journal-title":"Front Immunol"},{"key":"11120_CR41","doi-asserted-by":"publisher","unstructured":"Dong C, Ye DX, Zhang WB, Pan HY, Zhang ZY, Zhang L Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma. [cited 2024 Nov 6]; Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/jop.12296","DOI":"10.1111\/jop.12296"},{"key":"11120_CR42","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1111\/odi.14892","volume":"307","author":"L Peng","year":"2024","unstructured":"Peng L, Sun E, Zhang J, Cai L, Zheng J, Zeng Y (2024) The effect of c-Fos on the prognosis, proliferation, and invasion of oral squamous cell carcinoma. Oral Dis 307:4266\u20134277","journal-title":"Oral Dis"},{"key":"11120_CR43","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/07357907.2016.1217422","volume":"348","author":"S Wang","year":"2016","unstructured":"Wang S, Xu X, Xu F, Meng Y, Sun C, Shi L et al (2016) Combined expression of c-jun, c-fos, and p53 improves Estimation of prognosis in oral squamous cell carcinoma. Cancer Invest 348:393\u2013400","journal-title":"Cancer Invest"},{"issue":"1","key":"11120_CR44","volume":"5","author":"S Gupta","year":"2015","unstructured":"Gupta S, Kumar P, Kaur H, Sharma N, Saluja D, Bharti AC et al (2015) Selective participation of c-Jun with Fra-2\/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer. Sci Rep 5(1):16811","journal-title":"Sci Rep"},{"key":"11120_CR45","doi-asserted-by":"crossref","unstructured":"Kuonen F, Li NY, Haensel D, Patel T, Gaddam S, Yerly L et al (2021) c-FOS drives reversible basal to squamous cell carcinoma transition. Cell Rep. ;37[1]:109774.","DOI":"10.1016\/j.celrep.2021.109774"},{"issue":"4","key":"11120_CR46","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3892\/ijo.2016.3661","volume":"49","author":"C Tang","year":"2016","unstructured":"Tang C, Jiang Y, Shao W, Shi W, Gao X, Qin W et al (2016) Abnormal expression of FOSB correlates with tumor progression and poor survival in patients with gastric cancer. Int J Oncol 49(4):1489\u20131496","journal-title":"Int J Oncol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11120-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11120-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11120-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:03:53Z","timestamp":1766898233000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11120-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11120"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11120-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the authors have read the manuscript and consent to publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"1022"}}